Director Simeon George buys $27.2 million of ADARx Pharmaceuticals, Inc. (ADRX)
Simeon George, director, bought $27.2 million of stock. WallStPal Score 62.
Simeon George, director of ADARx Pharmaceuticals, Inc., bought 1,600,000 shares on the open market on September 28, 2026 at an average of $17.00 a share, for a total of $27.2 million. The purchase was reported to the SEC on Form 4 on September 29, 2026.
It is a new position: the filing shows no shares held directly before this purchase.
4 other insiders also bought at least $10,000 of ADRX within 30 days, which makes this a cluster buy.
In the 12 months up to this filing, ADARx Pharmaceuticals, Inc. insiders reported 2 open-market purchases and 0 sales.
WallStPal Score: 62 out of 100, because of a brand-new position; a large purchase; 4 other insiders also bought.
It is too soon to say how the stock did afterward. This page will update as prices come in.
Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.
Examples
Big insider purchases have made news before. In January 2016, with bank stocks falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares, about $26 million of his own money, and the purchase was widely reported as a sign of confidence.
Explain it like I'm 13
Simeon George helps run ADARx Pharmaceuticals, Inc.. Spending $27.2 million of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.
More: all ADRX insider trades · Simeon George's track record